Crispr Therapeutics AG (CRSP) — Financial Flexibility Index
Crispr Therapeutics AG (CRSP) has a Financial Flexibility Index of -0.12x as of March 2026. Free cash flow of $-108.39 Million (operating CF $-108.90 Million minus capex $504.00K) represents 0% of total liabilities ($911.26 Million). Check CRSP strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Crispr Therapeutics AG Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Crispr Therapeutics AG across 12 annual periods. See Crispr Therapeutics AG short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Crispr Therapeutics AG (2014–2025)
Year-by-year free cash flow to debt coverage for Crispr Therapeutics AG. For the full company profile including market capitalisation, see Crispr Therapeutics AG stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-344.10 Million | $-345.01 Million | $343.43 Million | ▼ -120.5% |
| 2024 | -0.45x | $-140.87 Million | $-142.77 Million | $309.95 Million | ▲ +37.2% |
| 2023 | -0.72x | $-250.91 Million | $-260.38 Million | $346.77 Million | ▲ +42.0% |
| 2022 | -1.25x | $-458.55 Million | $-495.74 Million | $367.58 Million | ▼ -170.8% |
| 2021 | 1.76x | $620.68 Million | $538.97 Million | $352.42 Million | ▲ +231.1% |
| 2020 | -1.34x | $-220.01 Million | $-238.37 Million | $163.73 Million | ▼ -370.0% |
| 2019 | 0.50x | $63.36 Million | $56.68 Million | $127.33 Million | ▲ +151.5% |
| 2018 | -0.97x | $-93.47 Million | $-96.24 Million | $96.82 Million | ▼ -29.4% |
| 2017 | -0.75x | $-62.28 Million | $-70.10 Million | $83.51 Million | ▼ -59.9% |
| 2016 | -0.47x | $-52.29 Million | $-55.31 Million | $112.12 Million | ▼ -245.2% |
| 2015 | 0.32x | $60.58 Million | $59.43 Million | $188.55 Million | ▲ +175.1% |
| 2014 | -0.43x | $-3.64 Million | $-4.79 Million | $8.50 Million | — |